Ningxia Zhongke Biotechnology Co., Ltd (SHA:600165)
China · Delayed Price · Currency is CNY 2.800
+0.010 (0.36%)
Nov 6, 2026, 2:14 PM CST
SHA:600165 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 95.63 | 460.65 | 8.61 | 24.4 | 89.48 | 110.95 |
Cash & Short-Term Investments | 95.63 | 460.65 | 8.61 | 24.4 | 89.48 | 110.95 |
Cash Growth | 1042.99% | 5252.30% | -64.73% | -72.73% | -19.35% | -46.46% |
Accounts Receivable | 130.99 | 110.38 | 69.84 | 60.36 | 35 | 21.74 |
Other Receivables | 37.07 | 37.31 | 5.24 | 3.35 | 2.49 | 1.58 |
Receivables | 168.06 | 147.69 | 75.07 | 63.71 | 37.49 | 23.32 |
Inventory | 195.15 | 117.28 | 102.05 | 95.83 | 109.31 | 144.97 |
Prepaid Expenses | - | 9.34 | 8.87 | 0.34 | 0.01 | - |
Other Current Assets | 88.66 | 56.81 | 19.64 | 14.42 | 15.57 | 32.91 |
Total Current Assets | 547.5 | 791.77 | 214.24 | 198.7 | 251.86 | 312.16 |
Property, Plant & Equipment | 1,658 | 1,620 | 1,808 | 1,872 | 2,198 | 2,231 |
Long-Term Investments | 5.15 | - | - | 710.41 | 672.17 | 652.02 |
Other Intangible Assets | 58.07 | 60.27 | 67.14 | 74.31 | 79.3 | 52.53 |
Long-Term Deferred Tax Assets | 2.22 | 2.16 | 4.55 | 3.05 | 2.9 | 6.09 |
Long-Term Deferred Charges | 3.23 | 3.8 | 5.07 | 6.23 | 6.8 | 7.65 |
Other Long-Term Assets | 27.37 | 12.29 | 67.99 | 92.81 | 67.53 | 44.37 |
Total Assets | 2,302 | 2,490 | 2,167 | 2,958 | 3,279 | 3,306 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 155.84 | 115.96 | 820.22 | 635.36 | 692.24 | 567.22 |
Accrued Expenses | 2.34 | 28.44 | 143.15 | 123.87 | 18.58 | 24.6 |
Short-Term Debt | 10 | 7.81 | 674.32 | 532.24 | 461.67 | 344.19 |
Current Portion of Long-Term Debt | 4.69 | 2.15 | - | 424.53 | 369.54 | 74.2 |
Current Portion of Leases | - | 0.52 | 1.66 | 1.23 | 0.75 | 0.32 |
Current Income Taxes Payable | 5.04 | 2.63 | - | - | 0.74 | 0.02 |
Current Unearned Revenue | 9.75 | 3.3 | 3.27 | 8.05 | 4.18 | 56.45 |
Other Current Liabilities | 91.49 | 124.82 | 254.87 | 155.78 | 18.83 | 13.04 |
Total Current Liabilities | 279.15 | 285.63 | 1,898 | 1,881 | 1,567 | 1,080 |
Long-Term Debt | - | 845.98 | - | 743.8 | 781.5 | 1,079 |
Long-Term Leases | 1.7 | 0.9 | 1.29 | 1.7 | 1.53 | 1.86 |
Long-Term Unearned Revenue | 19.1 | 19.49 | 17.63 | 18.26 | 19.9 | 12.91 |
Long-Term Deferred Tax Liabilities | 1.73 | 2.03 | 2.52 | 3.06 | 3.2 | 3.65 |
Other Long-Term Liabilities | 856.29 | - | 7.91 | 3.96 | 11.97 | 64.47 |
Total Liabilities | 1,158 | 1,154 | 1,927 | 2,652 | 2,385 | 2,242 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1,616 | 1,616 | 684.88 | 684.88 | 684.88 | 684.88 |
Additional Paid-In Capital | 1,253 | 1,253 | 957.74 | 442.27 | 442.04 | 441.79 |
Retained Earnings | -1,852 | -1,661 | -1,571 | -1,032 | -497.71 | -356.23 |
Comprehensive Income & Other | - | - | - | 3.93 | 0.1 | -0.12 |
Total Common Equity | 1,017 | 1,208 | 71.79 | 99.16 | 629.31 | 770.32 |
Minority Interest | 126.86 | 128.07 | 168.37 | 206.5 | 264.77 | 293.4 |
Shareholders' Equity | 1,144 | 1,336 | 240.17 | 305.65 | 894.08 | 1,064 |
Total Liabilities & Equity | 2,302 | 2,490 | 2,167 | 2,958 | 3,279 | 3,306 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 16.39 | 857.36 | 677.27 | 1,704 | 1,615 | 1,500 |
Net Cash (Debt) | 79.24 | -396.71 | -668.67 | -1,679 | -1,526 | -1,389 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | 0.03 | -0.25 | -0.98 | -2.45 | -2.23 | -2.03 |
Filing Date Shares Outstanding | 1,625 | 1,616 | 684.88 | 684.88 | 684.88 | 684.88 |
Total Common Shares Outstanding | 1,625 | 1,616 | 684.88 | 684.88 | 684.88 | 684.88 |
Working Capital | 268.35 | 506.14 | -1,683 | -1,682 | -1,315 | -767.88 |
Book Value Per Share | 0.63 | 0.75 | 0.10 | 0.14 | 0.92 | 1.12 |
Tangible Book Value | 958.94 | 1,148 | 4.65 | 24.84 | 550.01 | 717.79 |
Tangible Book Value Per Share | 0.59 | 0.71 | 0.01 | 0.04 | 0.80 | 1.05 |
Buildings | - | 552.92 | 643.45 | 669.89 | 767.23 | 607.44 |
Machinery | - | 1,582 | 1,579 | 1,521 | 1,623 | 1,078 |
Construction In Progress | - | 81.39 | 79.43 | 72.79 | 74.65 | 696.41 |